Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium. [electronic resource]
Producer: 20191224Description: 895-900 p. digitalISSN:- 1432-1041
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.